The Effect of Bevacizumab on the Trabeculectomy

Sponsor
Samsung Medical Center
Study ID
NCT01122966
Phase
PHASE2/PHASE3
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
20 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The investigators plan to evaluate the additive effect of intracameral and subconjunctival injections of bevacizumab in trabeculectomies with other antimetabolites.

Key Dates

First listed
May 13, 2010
Start date
Mar 31, 2010
Status verified
May 2010
Primary completion
Mar 31, 2011
Completion
Mar 31, 2012

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: trabeculectomy
    Subjects who have trabeculectomies with intraocular bevacizumab injection

Primary Outcome Measure

intraocular pressure [ Time Frame: on postoperative 1month ]

Central Contacts

Related Studies